Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Ilika losses narrow in year of progress
(Sharecast News) - Solid-state battery technology developer Ilika reported full-year growth in a trading update on Thursday, alongside significant advancements in its 'Stereax' manufacturing and 'Goliath' product development. The AIM-traded firm said that for the year ended 30 April, its unaudited revenue reached around £2.1m, up from £0.7m in the 2023 financial year.
It recorded an EBITDA loss, excluding share-based payments, of around £4.5m, narrowing from £7m a year earlier.
As of 30 April, Ilika held £11.9m in cash and cash equivalents, compared to £15.8m at the end of April 2023.
On the operational front, Ilika said it had made substantial progress in transferring the manufacturing of its thin-film Stereax miniature solid-state batteries (SSBs) to Cirtec Medical.
The batteries are designed for use in medical devices and industrial wireless sensors in specialised environments.
Additionally, Ilika said it achieved significant milestones in the development of its large-format Goliath cells, intended for electric vehicles (EVs) and cordless appliances.
The company recently announced a partnership with Agratas, a Tata Group global battery business, as part of its 'SiSTEM; grant-funded scale-up activities.
In collaboration with Agratas, Ilika had entered into a 12-month agreement to facilitate interactions supporting the company's development milestone of D8 - 50Ah, chemistry frozen - by the first half of 2025.
That milestone would be crucial for licensing opportunities and exploring broader collaboration possibilities.
On 10 May, Ilika announced a capital raising through a conditional placing of new shares, raising gross proceeds of £1.7m.
An open offer for new shares aimed to raise an additional £1.7m, providing further support for the development of its Goliath solid-state battery, the board explained.
Ilika said it expected to announce its audited full-year results for the 12 months ended 30 April on 11 July.
At 1626 BST, Ilika shares were down 2.63% at 27.75p.
Reporting by Josh White for Sharecast.com.
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Doing Business with Fidelity | Diversity, Equity & Inclusion Reports | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Security | Statutory and Regulatory disclosures | Whistleblowing policy
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.
